Brain Tumour Research is pleased to welcome Nick Dawe to its Board of Trustees.
Nick’s motivation to help find a cure for brain tumours comes after his five-year-old son, Oliver, was diagnosed with a low-grade pilocytic astrocytoma in December 2019. Oliver underwent a full resection to remove the tumour and has gone on to make a remarkable recovery.
Nick said: “Many, many other families are not so lucky. Brain tumours kill more children and adults under the age of 40 than any other cancer yet, historically, just 1% of the national spend on cancer research has been allocated to this devastating disease. I want to do all I can to change that.”
Oliver’s diagnosis prompted Nick to step back from his career in the medical device industry which included 11 years specialising in the neurosurgical field. He plans to return to a career in the industry.
Wendy Fulcher, Chair of the Board of Trustees at Brain Tumour Research, said: “Nick has been inspired by the positive impact medical research and technology can have on the life of a patient and has very personal experience of the impact of a brain tumour diagnosis. We are delighted to welcome him to the Board.”
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.